Genetic Variants in TP53 and Type 2 Diabetes
Author Information
Author(s): Burgdorf Kristoffer Sølvsten, Grarup Niels, Justesen Johanne Marie, Harder Marie Neergaard, Witte Daniel Rinse, Jørgensen Torben, Sandbæk Annelli, Lauritzen Torsten, Madsbad Sten, Hansen Torben, DIAGRAM Consortium, Pedersen Oluf
Primary Institution: Hagedorn Research Institute, Copenhagen, Denmark
Hypothesis
The study aimed to replicate associations of genetic variants with type 2 diabetes in a Danish population.
Conclusion
The G-allele of TP53 rs1042522 is associated with an increased prevalence of type 2 diabetes in a combined analysis of 55,521 Europeans.
Supporting Evidence
- The G-allele of TP53 rs1042522 showed significant association with type 2 diabetes in a meta-analysis.
- None of the nine investigated variants were significantly associated with type 2 diabetes in the Danish samples.
- The study included a total of 10,157 Danish individuals from four different study groups.
Takeaway
Scientists looked at genes to see if they affect diabetes risk, and found one gene that seems to increase the chance of getting diabetes.
Methodology
The study involved genotyping nine lead variants in a case-control study of Danish individuals and meta-analysis with data from the DIAGRAM+ Consortium.
Potential Biases
The meta-analysis included data from the FUSION study, which may introduce bias.
Limitations
The study could not replicate all findings from previous studies and had limited power to detect low-impact genetic effects.
Participant Demographics
The study included Danish individuals, with a total of 10,157 participants from various study groups.
Statistical Information
P-Value
0.0032
Confidence Interval
1.02–1.11
Statistical Significance
p=0.0032
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website